Cargando…
Adjuvant Treatment for Protocadherin 19 (PCDH19) Syndrome
Protocadherin 19 (PCDH19) syndrome is inherited as an X-linked pattern and affects mainly females. This syndrome is caused by a mutation in the PCDH19 gene encoding for the protocadherin protein. It is characterized by refractory seizures during febrile episodes with neuropsychiatric manifestations....
Autores principales: | Moncayo, Juan A, Vargas, Maite N, Castillo, Isabel, Granda, Pablo V, Duque, Andrea M, Argudo, Jennifer M, Matcheswalla, Sakina, Lopez Dominguez, Guillermo E, Monteros, Gustavo, Andrade, Andres F, Ojeda, Diego, Yepez, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392850/ https://www.ncbi.nlm.nih.gov/pubmed/36004035 http://dx.doi.org/10.7759/cureus.27154 |
Ejemplares similares
-
Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology
por: Moncayo, Juan A, et al.
Publicado: (2022) -
Biallelic mutation of Protocadherin-21 (PCDH21) causes retinal degeneration in humans
por: Henderson, Robert H., et al.
Publicado: (2010) -
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016) -
Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα)
por: Pham, Duyen H., et al.
Publicado: (2017) -
Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2014)